{"nctId":"NCT00395460","briefTitle":"Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients","startDateStruct":{"date":"2006-09"},"conditions":["Central Nervous System Diseases"],"count":147,"armGroups":[{"label":"Gadobutrol 0.1 mmol/kg Body Weight (BW) (Gadavist, BAY86-4875)","type":"EXPERIMENTAL","interventionNames":["Drug: Gadobutrol (Gadavist, Gadovist, BAY86-4875)"]},{"label":"GD 0.1 mmol/kg BW (Magnevist, BAY86-4882)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Magnevist"]}],"interventions":[{"name":"Gadobutrol (Gadavist, Gadovist, BAY86-4875)","otherNames":[]},{"name":"Magnevist","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Chinese origin, with known or suspected brain or spine diseases\n\nExclusion Criteria:\n\n* Pregnancy\n* Lactation\n* Conditions interfering with MRI\n* Allergy to any contrast agent or any drugs\n* Participation in other trial\n* Require emergency treatment\n* Severely impaired liver and kidney functions","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Contrast to Noise Ratio (CNR) Between Pre- and Post-contrast Magnetic Resonance Imaging (MRI) Scan of Central Nervous System (CNS) Lesions","description":"CNR = (signal intensity \\[SI\\] lesion - SI normal tissue) / standard deviation (SD) background. SI lesion is the signal intensity in the lesion, SI normal tissue is the signal intensity in the normal tissue, and SD background is the standard deviation of the background noise. The signal intensity (SI) on the pre-contrast and on the post-contrast MR scans was to be measured in the enhanced lesion, normal tissue and background.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50.41","spread":"38.448"},{"groupId":"OG001","value":"43.47","spread":"39.178"}]}]}]},{"type":"SECONDARY","title":"Change in Number of Detected Lesions From Pre- to Post-contrast MRI Scan","description":"The number of lesions in the magnetic resonance scans was recorded before and after injection of contrast agent for the investigators and all 3 blinded readers (reader 2, reader 3 and reader 4).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"2.56"},{"groupId":"OG001","value":"0.1","spread":"0.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"6.94"},{"groupId":"OG001","value":"0.3","spread":"1.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"9.72"},{"groupId":"OG001","value":"0.3","spread":"1.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"2.72"},{"groupId":"OG001","value":"0.1","spread":"0.93"}]}]}]},{"type":"SECONDARY","title":"Change in Diagnostic Confidence From Pre- to Post-contrast Magnetic Resonance Imaging by Treatment","description":"The change in diagnostic confidence was assessed based on post-contrast compared to pre-contrast scans as \"improved\", \"unchanged\" or \"worsened\" for the investigators and all 3 blinded readers (reader 2, reader 3 and reader 4).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null},{"groupId":"OG001","value":"61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60","spread":null},{"groupId":"OG001","value":"63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Lesion Contrast Enhancement From Pre- to Post-contrast MRI","description":"The degree of contrast enhancement was recorded on a 4-point scale as follows: 1 = No: lesion is not enhanced. 2 = Moderate: lesion is weakly enhanced. 3 = Good: lesion is clearly enhanced. 4 = Excellent: lesion is clearly and brightly enhanced. In case of more than one lesion, the lesion with maximum enhancement was to be assessed. The change in lesion contrast enhancement was assessed based on post-contrast in comparison to pre-contrast scans for the investigators and all 3 blinded readers (reader 2, reader 3 and reader 4).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":"0.87"},{"groupId":"OG001","value":"2.2","spread":"0.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"1.21"},{"groupId":"OG001","value":"2.0","spread":"1.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"0.98"},{"groupId":"OG001","value":"1.6","spread":"0.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":"1.05"},{"groupId":"OG001","value":"2.1","spread":"1.09"}]}]}]},{"type":"SECONDARY","title":"Change in Lesion Delineation Between Pre- and Post-contrast MRI Scan of CNS Lesions","description":"Lesion delineation was recorded on a 4-point scale as follows: 1 = None: no or unclear delineation of the boundary between lesion and surrounding tissue; 2 = Moderate: some aspects of border delineation covered; 3 = Good: almost clear delineation, but not complete on relevant slices; 4 = Excellent: sharp and complete delineation. In case of more than one lesion, the lesion with maximum enhancement was assessed. Change in lesion delineation was assessed based on post-contrast in comparison to pre-contrast scans for investigators and all 3 blinded readers (reader 2, reader 3 and reader 4).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"0.73"},{"groupId":"OG001","value":"1.0","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"0.89"},{"groupId":"OG001","value":"1.3","spread":"0.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.71"},{"groupId":"OG001","value":"0.8","spread":"0.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"0.81"},{"groupId":"OG001","value":"0.9","spread":"0.67"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Contrast to Noise Ratio (CNR) Between Pre- and Post-contrast MRI Scan of CNS Lesions in Participants With Malignant Brain Tumor(s) / Brain Metastases","description":"CNR = (SI lesion - SI normal tissue) / SD background. SI lesion is the signal intensity in the lesion, SI normal tissue is the signal intensity in the normal tissue, and SD background is the standard deviation of the background noise. The signal intensity (SI) on the pre-contrast and on the post-contrast MR scans was to be measured in the enhanced lesion, normal tissue and background.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54.95","spread":"42.405"},{"groupId":"OG001","value":"46.56","spread":"30.074"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Contrast to Noise Ratio (CNR) Between Pre- and Post-contrast MRI Scan of Participants With CNS Lesions Other Than Primary Malignant Brain Tumor(s) / Brain Metastases","description":"CNR = (SI lesion - SI normal tissue) / SD background. SI lesion is the signal intensity in the lesion, SI normal tissue is the signal intensity in the normal tissue, and SD background is the standard deviation of the background noise. The signal intensity (SI) on the pre-contrast and on the post-contrast MR scans was to be measured in the enhanced lesion, normal tissue and background.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.51","spread":"36.985"},{"groupId":"OG001","value":"41.86","spread":"43.379"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Number of Detected Lesions From Pre- to Post-contrast MRI Scan of CNS Lesions in Participants With Malignant Brain Tumor(s) / Brain Metastases","description":"Investigators and blinded readers (reader 2, 3 and 4) were to record the number of lesions in the magnetic resonance scans before and after injection of contrast agent.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"2.61"},{"groupId":"OG001","value":"0.4","spread":"1.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"1.75"},{"groupId":"OG001","value":"0.2","spread":"0.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"2.18"},{"groupId":"OG001","value":"0.2","spread":"0.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"0.30"},{"groupId":"OG001","value":"0.0","spread":"0.20"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Number of Detected Lesions From Pre- to Post-contrast MRI Scan of Participants With CNS Lesions Other Than Primary Malignant Brain Tumor(s) / Brain Metastases","description":"Investigators and blinded readers (reader 2, 3 and 4= were to record the number of lesions in the magnetic resonance scans before and after injection of contrast agent.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"2.57"},{"groupId":"OG001","value":"0","spread":"0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"8.20"},{"groupId":"OG001","value":"0.3","spread":"2.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":"11.53"},{"groupId":"OG001","value":"0.3","spread":"1.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"3.24"},{"groupId":"OG001","value":"0.2","spread":"1.13"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":71},"commonTop":["Insomnia","Nausea","Alanine aminotransferase increased","Aspartate aminotransferase increased","Hyponatraemia"]}}}